Belinostat
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 348 publications
Tracing the Analytical Footprint of Belinostat: Exploring Pharmacology and Synthetic Framework.
Journal: Biomedical chromatography : BMC
Published: November 21, 2025
Characterization of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in Glioblastoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 04, 2025
Retraction Note: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer.
Journal: Journal of cancer research and clinical oncology
Published: October 21, 2025
Proteome-wide multi-trait association analyses prioritize candidate proteins and therapeutic targets for psychiatric disorders.
Journal: Journal of affective disorders
Published: August 22, 2025
Cross-resistance of Belinostat and Romidepsin in Non-T Follicular Helper Peripheral T-cell Lymphoma Models Suggests Subtype-Specific Implications for Belinostat-CHOP.
Journal: Molecular cancer therapeutics
Published: August 11, 2025
Comprehensive Analysis to Reveal Nitrogen Metabolism-Associated Genes as a Prognostic Index in Head and Neck Squamous Cell Cancer.
Journal: Current medicinal chemistry
Published: July 18, 2025
Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis.
Journal: Brain research
Published: June 25, 2025
Protein domain movement involved in binding of belinostat and HPOB as inhibitors of histone deacetylase 6 (HDAC6): a hybrid automated-interactive docking study.
Journal: Journal of computer-aided molecular design
Published: May 28, 2025
EXPRESSION OF CONCERN: Growth Inhibition of Pancreatic Cancer Cells by Histone Deacetylase Inhibitor Belinostat Through Suppression of Multiple Pathways Including Hif, Nfkb, and Mtor Signaling In Vitro and In Vivo.
Journal: Molecular carcinogenesis
Published: May 26, 2025
CREB binding protein (CREBBP): Structure-based perspectives for the development of clinical inhibitors.
Journal: Translational oncology
Published: May 20, 2025
Geranylgeranyl transferase-1 inhibitor GGTI-2417 enhances the anti-tumour efficacy of histone deacetylase inhibitors in different T-cell lymphoma lines.
Journal: British journal of haematology
Published: April 11, 2025
Last Updated: 04/28/2026